<SEC-DOCUMENT>0000842023-12-000018.txt : 20120731
<SEC-HEADER>0000842023-12-000018.hdr.sgml : 20120731
<ACCEPTANCE-DATETIME>20120731090052
ACCESSION NUMBER:		0000842023-12-000018
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20120731
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20120731
DATE AS OF CHANGE:		20120731

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TECHNE CORP /MN/
		CENTRAL INDEX KEY:			0000842023
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				411427402
		STATE OF INCORPORATION:			MN
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-17272
		FILM NUMBER:		12995405

	BUSINESS ADDRESS:	
		STREET 1:		614 MCKINLEY PL N E
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
		BUSINESS PHONE:		6123798854

	MAIL ADDRESS:	
		STREET 1:		614 MCKINLEY PLACE NE
		CITY:			MINNEAPOLIS
		STATE:			MN
		ZIP:			55413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>k8div.txt
<DESCRIPTION>8-K
<TEXT>
                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549

                                FORM 8-K

                              CURRENT REPORT

                  PURSUANT TO SECTION 13 OR 15(d) OF THE
                     SECURITIES EXCHANGE ACT OF 1934

    Date of report (Date of earliest event reported): July 31, 2012

                            TECHNE CORPORATION
             (Exact Name of Registrant as Specified in Charter)


       Minnesota                     0-17272             41-1427402
(State or Other Jurisdiction       (Commission         I.R.S. Employer
of Incorporation)                  File Number)      Identification No.)

                614 Mckinley Place NE
                   Minneapolis, MN                       55413
       (Address of Principal Executive Offices)       (Zip Code)

     Registrant's telephone number, including area code:  (612) 379-8854

                              Not Applicable
      (Former Name or Former Address, if changed since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligations of the registrant under any
of the following provisions:

/ /   Written communications pursuant to Rule 425 under the Securities Act
      17 CFR 230.425)

/ /   Soliciting material pursuant to Rule 14a-12 under the Exchange Act
      (17 CFR 240.14a-12)

/ /   Pre-commencement communications pursuant to Rule 14d-2(b) under the
      Exchange Act (17 CFR 240.14d-2(b))

/ /   Pre-commencement communications pursuant to Rule 13e-4(c) under the
      Exchange Act (17 CFR 240.13e-4(c))


<PAGE>




Item 8.01  Other Events

A copy of the press release issued by Techne Corporation on July 31, 2012,
announcing a cash dividend is attached hereto as Exhibit 99.1.



Item 9.01 Financial Statements and Exhibits

     (d) Exhibits

         99.1 Press Release dated July 31, 2012.








                            SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


Dated: July 31, 2012                    TECHNE CORPORATION
                                      By: /s/ Thomas E. Oland
                                      ---------------------------
                                      Name: Thomas E. Oland
                                      Title: President and Chief
                                        Executive Officer



                          EXHIBIT INDEX

    Exhibit No. Description
    ----------- -----------

    99.1 Press release of Techne Corporation dated July 31, 2012.


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>july12dividend.txt
<DESCRIPTION>DIVIDEND PRESS RELEASE
<TEXT>
          TECHNE CORPORATION DECLARES DIVIDEND


Minneapolis/July 31, 2012/ -- Techne Corporation (NASDAQ:TECH)
announced that its Board of Directors has decided to pay a dividend of
$0.28 per share for the quarter ended June 30, 2012.  The quarterly
dividend will be payable August 24, 2012 to all common shareholders of
record on August 10, 2012.  Future cash dividends will be considered
by the Board of Directors on a quarterly basis.


            *  *  *  *  *  *  *  *  *  *  *  *  *  *

Techne Corporation has two operating subsidiaries:  Research and
Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and
R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England.  R&D
Systems is a specialty manufacturer of biological products.  R&D
Systems has three operating subsidiaries, BiosPacific, Inc.
(BiosPacific), located in Emeryville, California, Boston Biochem,
Inc., located in Cambridge, Massachusetts and R&D Systems China Co.
Ltd., (R&D China), located in Shanghai, China.  BiosPacific is a
worldwide supplier of biologics to manufacturers of in vitro
diagnostic systems and immunodiagnostic kits. Boston Biochem is a
leading developer and manufacturer of ubiquitin-related research
products. R&D China and R&D Europe distribute biotechnology products.
R&D Europe has two subsidiaries, Tocris Holding, Ltd (Tocris) of
Bristol, England and R&D Systems GmbH, a German sales operation.
Tocris is a leading supplier of reagents for non-clinical life science
research.

Contact:  Greg Melsen, Chief Financial Officer
          Kathy Backes, Controller
          (612) 379-8854


</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
